The Surge of Weight Loss Treatments and a New Tracker

This chapter discusses the surge of weight loss treatments in the pharmaceutical industry and introduces a tracker that monitors the development of these drugs. They discuss the collected data, its application in tracking progress in clinical trials, and the growing interest from pharmaceutical companies in acquiring early stage drug candidates for obesity.